152 related articles for article (PubMed ID: 28829509)
21. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
[TBL] [Abstract][Full Text] [Related]
23. Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR.
Rubenstein M; Hollowell CM; Guinan P
Med Oncol; 2010 Dec; 27(4):1212-8. PubMed ID: 19937163
[TBL] [Abstract][Full Text] [Related]
24. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
[TBL] [Abstract][Full Text] [Related]
25. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
[TBL] [Abstract][Full Text] [Related]
26. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes.
Hong X; Mao L; Xu L; Hu Q; Jia R
Bioengineered; 2022 Jan; 13(1):995-1012. PubMed ID: 34974814
[TBL] [Abstract][Full Text] [Related]
28. Detection of pelvic lymph node micrometastasis by real-time reverse transcriptase polymerase chain reaction in prostate cancer patients after hormonal therapy.
Liu DY; Xia WM; Tang Q; Wang J; Wang MW; Wang Y; Wang SJ; Ye YF; Zhou WL; Shao Y
J Cancer Res Clin Oncol; 2014 Feb; 140(2):235-41. PubMed ID: 24292502
[TBL] [Abstract][Full Text] [Related]
29. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
30. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer.
Turcotte S; Forget MA; Beauseigle D; Nassif E; Lapointe R
Neoplasia; 2007 Oct; 9(10):788-96. PubMed ID: 17971898
[TBL] [Abstract][Full Text] [Related]
31. Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells.
Liu T; Mendes DE; Berkman CE
Int J Oncol; 2014 Mar; 44(3):918-22. PubMed ID: 24424840
[TBL] [Abstract][Full Text] [Related]
32. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
[TBL] [Abstract][Full Text] [Related]
33. PSMA-PSA clones controlled by full Akt phosphorylation (T308+,S473+) recapitulate molecular features of human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Horchani A; Oueslati R
Tunis Med; 2015; 93(8-9):556-64. PubMed ID: 26815524
[TBL] [Abstract][Full Text] [Related]
34. Bispecific oligonucleotides may induce interferon expression in LNCaP cells enhancing surface antigen expression: effect of intrastrand base pair complementarity.
Rubenstein M; Hollowell CM; Guinan P
In Vivo; 2011; 25(1):61-7. PubMed ID: 21282736
[TBL] [Abstract][Full Text] [Related]
35. Expression of prostate-specific membrane antigen in normal and malignant human tissues.
Kinoshita Y; Kuratsukuri K; Landas S; Imaida K; Rovito PM; Wang CY; Haas GP
World J Surg; 2006 Apr; 30(4):628-36. PubMed ID: 16555021
[TBL] [Abstract][Full Text] [Related]
36. PSMA expression is highly homogenous in primary prostate cancer.
Tsourlakis MC; Klein F; Kluth M; Quaas A; Graefen M; Haese A; Simon R; Sauter G; Schlomm T; Minner S
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):449-55. PubMed ID: 26153794
[TBL] [Abstract][Full Text] [Related]
37. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
Ghadersohi A; Odunsi K; Zhang S; Azrak RG; Bundy BN; Manjili MH; Li F
Int J Cancer; 2008 Sep; 123(6):1376-84. PubMed ID: 18567002
[TBL] [Abstract][Full Text] [Related]
38. Study of PSA, PSMA and hK2 mRNA in peripheral blood of prostate cancer patients and its clinical implications.
Xu T; Chen X; Wang XF; Hou SK; Zhu JC; Zhang XD; Huang XB
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):164-8. PubMed ID: 15100735
[TBL] [Abstract][Full Text] [Related]
39. PDEF is a negative regulator of colon cancer cell growth and migration.
Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK
J Cell Biochem; 2009 Dec; 108(6):1389-98. PubMed ID: 19830706
[TBL] [Abstract][Full Text] [Related]
40. Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.
Peng W; Guo L; Tang R; Liu X; Jin R; Dong JT; Xing CG; Zhou W
Prostate; 2019 Mar; 79(4):370-378. PubMed ID: 30488457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
